GIA
SPPI

Gargoyle Investment Advisor’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Gargoyle Investment Advisor’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-25,800
Closed -$202K – 153
2014
Q1 		$202K Sell
25,800
-29,330
-53% -$248K 0.09% 127
2013
Q4 		$488K Buy
+55,130
New +$492K 0.23% 101
2013
Q3 		– Sell
-39,017
Closed -$291K – 131
2013
Q2 		$291K Buy
+39,017
New +$299K 0.15% 111

Other funds holding SPPI

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Gargoyle Investment Advisor's SPPI Position: Q2 2014 in Review

Gargoyle Investment Advisor sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2014, closing a stake of 25,800 shares — an estimated $202K sold.

Gargoyle Investment Advisor first reported a position in SPPI in Q2 2013 and held it in 3 quarters. The position peaked at $488K in Q4 2013. 126 funds tracked by Wall St. Rank hold SPPI as of Q2 2014.

  • Gargoyle Investment Advisor reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 25,800 Spectrum Pharmaceuticals Inc shares in Q2 2014, an estimated $202K.
  • Gargoyle Investment Advisor first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Gargoyle Investment Advisor's Spectrum Pharmaceuticals Inc position peaked at $488K in Q4 2013.
  • 126 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2014.

Based on Gargoyle Investment Advisor's 13F filing for Q2 2014, filed 11 Aug 2014.